EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis

Timothy G Brandon iD, Rui Xiao, Daniel J Lovell iD, Edward Oberle iD, Matthew L Stoll iD, Nancy A Chauvin, Michael L Francavilla, Walter P Maksymowych iD, Pamela F Weiss iD

Arthritis Care & Research · 2025

DOI: 10.1002/acr.25565 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Timothy G Brandon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Axial Spondyloarthritis, Tumor Necrosis Factor Inhibitors, Antirheumatic Agents, Arthritis, Juvenile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to determine a core set of measures for youth with juvenile spondyloarthritis and axial disease (axJSpA), using the juvenile arthritis working group Outcome Measures in Rheumatology framework.

Methods

This was a prospective multicenter study of youth with axJSpA.

Participants

(aged 8–18 years) all initiated tumor necrosis factor inhibitor (TNFi) therapy and completed questionnaires, examinations, and magnetic resonance imaging (MRI) at baseline and 12 weeks. Responsiveness and discrimination were assessed using standardized response mean (SRM) and standardized mean difference (SMD). For highly correlated (r > |0.80|) items within domains, larger SRM and SMD were prioritized, and minimal clinically important improvement was determined for each.

Results

Of the evaluable cohort (N = 57), 68.4% were male, and the median age was 15.3 years; 70.2% of youth treated with TNFi had clinical response (change ≥2 in patient global assessment). Although 58% had continued MRI inflammation, 77% of those patients reported moderate clinical improvement. The final axJSpA core set contained the following: Patient‐Reported Outcomes Measurement Information System (PROMIS) pain interference (SRM 0.77, SMD 0.5), the sacroiliac joint inflammation score (SRM 1.02, SMD 0.52), PROMIS mobility (SRM 0.83, SMD 0.75), and patient global well‐being (SRM 0.88, SMD not applicable). All overall and composite disease activity measures tested, except the physician global assessment, had high SRM and SMD. Subgroup analysis demonstrated differences by biologic sex and overweight status. Improvement in the MRI inflammation score was greater in male patients. Improvement in the PROMIS pain interference and mobility measures was greater in those with normal body mass index.

Conclusion

A set of measures was developed for youth with axJSpA. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Axial SpondyloarthritisTumor Necrosis Factor InhibitorsAntirheumatic AgentsArthritis, JuvenilePragmatic Clinical Trials as TopicPatient Reported Outcome MeasuresHumansMaleAdolescentFemaleChildProspective StudiesMagnetic Resonance ImagingTreatment Outcome

Substanzen

Tumor Necrosis Factor InhibitorsAntirheumatic Agents

Autor:innen und Institutionen

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Perelman School of Medicine, University of Pennsylvania, and Children's Hospital of Philadelphia.
  • Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
  • Nationwide Children's Hospital and The Ohio State University, Columbus.
  • University of Alabama at Birmingham.
  • The Imaging Institute, The Cleveland Clinic, Cleveland, Ohio.

ORCID-Profile: Timothy G Brandon, Daniel J Lovell, Edward Oberle, Matthew L Stoll, Walter P Maksymowych, Pamela F Weiss

Förderung

  • NIAMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Brandon, T. G., Xiao, R., Lovell, D. J., Oberle, E., Stoll, M. L., Chauvin, N. A., Francavilla, M. L., Maksymowych, W. P., & Weiss, P. F. (2025). Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis. Arthritis Care & Research. https://doi.org/10.1002/acr.25565

Vancouver

Brandon TG, Xiao R, Lovell DJ, Oberle E, Stoll ML, Chauvin NA, et al. Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis. Arthritis Care & Research. 2025. doi:10.1002/acr.25565

BibTeX
@article{Brandon2025,
  author = {Brandon, Timothy G and Xiao, Rui and Lovell, Daniel J and Oberle, Edward and Stoll, Matthew L and Chauvin, Nancy A and Francavilla, Michael L and Maksymowych, Walter P and Weiss, Pamela F},
  title = {Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis},
  journal = {Arthritis Care & Research},
  year = {2025},
  doi = {10.1002/acr.25565}
}
Kostenlos starten →